An objective measure of response on whole-body MRI in metastatic hormone sensitive prostate cancer treated with androgen deprivation therapy, external beam radiotherapy, and radium-223.

Valentina GiacomettiArthur C GreyAaron J McCannKevin M PriseAlan R HounsellConor K McGarryPhilip G TurnerJoe M O'Sullivan

Published in: The British journal of radiology (2024)

Measurements of T1w WBMRI normalized intensity may allow identifying potentially useful response biomarkers correlating with survival, radiological response and biochemical progression.

Keyphrases

prostate cancer
magnetic resonance imaging
squamous cell carcinoma
small cell lung cancer
early stage
radiation therapy
stem cells
contrast enhanced
mesenchymal stem cells
locally advanced
cell therapy
chemotherapy induced